Keyphrases
T Cells
100%
T Cell Clone
100%
Differential Expression
100%
Phosphodiesterase-4 (PDE4)
100%
Myelin Basic Protein
100%
Phosphodiesterase 3 (PDE3)
100%
Cyclic nucleotide Phosphodiesterase
100%
Autoreactive
60%
Autoimmune Disease
40%
Lymphocytes
40%
CD4+ T Cells
40%
PDE4 Inhibitor
40%
Quantitative PCR
20%
Multiple Sclerosis
20%
Amino Acids
20%
Multiple Sclerosis Treatment
20%
Therapeutic Effect
20%
High Affinity
20%
Phosphodiesterase
20%
Immunodominant
20%
CD4+ T
20%
Experimental Autoimmune Encephalomyelitis
20%
3H-thymidine Incorporation
20%
Rolipram
20%
PDE3A
20%
Relative Distribution
20%
Cilostamide
20%
PDE3B
20%
Protein Epitopes
20%
Neuroscience
Myelin Basic Protein
100%
Cyclic Nucleotide Phosphodiesterase
100%
Phosphodiesterase IV
100%
Phosphodiesterase III
100%
T Cell
100%
CD4
37%
Autoimmune Disease
25%
PDE4 Inhibitors
25%
Messenger RNA
25%
Multiple Sclerosis
12%
Myelin Protein
12%
Cyclic Adenosine Monophosphate
12%
Treatment of Multiple Sclerosis
12%
Rolipram
12%
Phosphodiesterase
12%
Amino Acid
12%
DNA Synthesis
12%
Experimental Autoimmune Encephalomyelitis
12%
Epitope
12%
Reverse Transcription Polymerase Chain Reaction
12%
Lymphocyte
12%
Pharmacology, Toxicology and Pharmaceutical Science
Phosphodiesterase IV
100%
Myelin Basic Protein
100%
Cyclic Nucleotide Phosphodiesterase
100%
Phosphodiesterase III
100%
Phosphodiesterase IV Inhibitor
40%
Autoimmune Disease
40%
Multiple Sclerosis
40%
Messenger RNA
40%
Therapeutic Effect
20%
Rolipram
20%
Amino Acid
20%
Phosphodiesterase
20%
Experimental Autoimmune Encephalomyelitis
20%
Cilostamide
20%
Thymidine
20%
Epitope
20%
Myelin Protein
20%
Immunology and Microbiology
Cell Clone
100%
T Cell
100%
Myelin
100%
Lymphocyte Clone
80%
T-Helper Cell
40%
Autoimmune Disease
40%
PDE4 Inhibitors
40%
Epitope
20%
Treatment of Multiple Sclerosis
20%
Multiple Sclerosis
20%
Experimental Autoimmune Encephalomyelitis
20%
CD4+ T Lymphocyte
20%
Rolipram
20%
DNA Synthesis
20%
Lymphocyte
20%
Reverse Transcription Polymerase Chain Reaction
20%
Amino Acid
20%